A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 51/04 (2006.01) A61K 47/22 (2006.01) A61P 19/00 (2006.01) A61P 35/00 (2006.01) A61P 35/04 (2006.01)
Patent
CA 2371728
The present invention relates to a method of suppressing bone marrow (BM) and treating conditions that arise in or near bone such as cancer, myeloproliferative diseases, autoimmune diseases, infectious diseases, metabolic diseases or genetic diseases, with compositions having as their active ingredient a radionuclide complexed with a chelating agent such as macrocyclic aminophosphonic acid.
La présente invention concerne un procédé de suppression de la moelle osseuse et de traitement des états qui apparaissent dans la moelle osseuse ou près d'elle tels que le cancer, les syndromes myéloprolifératifs, les maladies auto-immunes, les maladies infectieuses, les maladies métaboliques ou les maladies génétiques, le traitement se faisant au moyen de compositions dont le composant actif est un radionucléide formant un complexe avec agent chélateur tel que l'acide macrocyclique aminophosphonique.
Abrams Paul G.
Bryan James Kyle
Fritzberg Alan R.
Hylarides Mark D.
John Elizabeth K.
Abrams Paul G.
Bryan James Kyle
Hylarides Mark D.
John Elizabeth K.
Neorx Corporation
LandOfFree
High dose radionuclide complexes for bone marrow suppression does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with High dose radionuclide complexes for bone marrow suppression, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and High dose radionuclide complexes for bone marrow suppression will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1869012